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Background: Endometriosis is a gynaecological disorder that affects 6–10 % of female population. It is characterized by
the presence of endometrial tissue outside the uterus, most often in the pelvic peritoneum or ovaries. Recent studies
have indicated that mesenchymal endometrial stem cells might get involved in endometriosis progression. Although
germ line stem cells have been proved to exist in the ovary, their involvement in ovarian endometriosis has not been
investigated. In this preliminary report we aimed to identify germinal stem cell markers in ovarian endometriosis.
Findings: Ten paraffin-embedded ovarian endometriosis samples were screened for germ cell-specific proteins DDX4
(VASA) and IFITM3, and its relation with stem cell marker OCT4, proliferation marker PCNA and estrogen receptor alpha
(ESR1), by immunohistochemistry, immunofluorescence and PCR. DDX4 and IFITM3 proteins were expressed in isolated
cells and clusters of cells in the cortical region of ovarian endometriotic cysts. DDX4 and IFITM3 co-localized in cells from
endometriotic stroma, and DDX4/IFITM3-expressing cells were positive for ESR1, OCT4 and PCNA. No cells expressing
neither DDX4 nor IFITM3 were detected in normal endometrial tissue.
Conclusion: The identification of germ cell-specific proteins DDX4 and IFITM3 provides the first evidence of
ovarian-sourced cells in ovarian endometriotic lesions and opens up new directions towards understanding the still
confusing pathogenesis of endometriosis.
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Introduction
Endometriosis is an estrogen-dependent benign chronic
and multifactorial gynaecological disorder, characterized by
the presence of endometrial tissue outside the uterus, most
often in the pelvic peritoneum or ovaries [1, 2]. Its preva-
lence is estimated to be 6–10 % in the general female popu-
lation and 35–50 % in patients with infertility [1]. The
lesions in the ovaries are predominantly hemorrhagic and
characterized by invagination and invasion of the* Correspondence: fraunhoffer.nicolas@maimonides.edu
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was first described by Carl von Rokitansky [4] in 1860;
however, it still remains an enigmatic disease. Several the-
ories have been proposed regarding the pathogenesis
of endometriosis. The most accepted one is the “back
flow” theory (retrograde menstruation) proposed by
John Sampson [5] in 1925, which suggests that endo-
metrial fragments in menstrual blood are taken over
through the tubal pavilion into the peritoneal cavity
initiating an endometriosis lesion. Recently, it has
been postulated that endometriosis can arise from a
small population of mesenchymal stem/stromal cells
(eMSC) residing in the endometrial tissue [6, 7]. This
point of view was supported by the identification of
undifferentiating markers such as C-KIT and OCT4
into the endometrial and ectopic endometriosis tis-
sues [8, 9].rticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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mammalian ovary has a finite, non-renewable oocyte pool
has been challenged by the finding, in the adult mouse
ovary, of a small population of germ line stem cells which
could differentiate into oogonia, enter meiosis and
contribute to oocyte replenishment [10]. Since then,
evidence claimed to be for and against the possibility
of oogenesis de novo in the adult mammalian ovary
has accumulated [11]. Whether germ line stem cells
contribute to oogenesis and follicle formation in vivo
has not been proven yet [12]. However, germ line stem
cells appear to exist in the adult ovary as shown by in-
dependent investigations in human, mouse and rat
[13–15]. Moreover, isolated germ line stem cells can
be manipulated in vitro to give rise to offspring after
transplantation [13].
Whether, and how, germ line ovarian stem cells might
contribute to the establishment and progression of ovarian
endometriosis has not been yet investigated. In this study,
we looked for the presence of ovarian stem cells in ovarian
endometriosis lesions. We identified cells expressing VASA
(DDX4) and IFITM3 germ line-specific markers known to
be implicated in different cellular processes including germ-
cell homing and maturation [16, 17].
Materials and methods
Patients and samples
This study was reviewed and approved by the Research Eth-
ics Committee of Universidad Maimónides and the Ethics
Committee from Clínica San Nicolás, Buenos Aires prov-
ince, Argentina. Clinical paraffin-embedded samples of
endometriosis and normal endometrial tissues were ob-
tained from the repository of the Pathology Department of
the Hospital Eva Perón, Buenos Aires province, Argentina.
Endometriosis samples (n = 10) belonged to patients aged
between 18 and 34 years, and endometrial tissues (n = 4)
from patients aged between 32 and 45 years old, undergoing
hysterectomy for benign pathologies.
Immunohistochemistry
Samples were baked overnight at 60 °C, dewaxed in xylene
and hydrated through a decreasing ethanol series (100, 80,
and 50 %). After 10 min in PBS, the heat-induced epitope
retrieval was performed by thermic bath at 96 °C in 10 mM
sodium citrate (pH 6) during 20 min. Endogenous peroxid-
ase activity was blocked with 3 % H2O2 in methanol for
30 min, and washed twice in 0.01 % Tween 20 in PBS buffer
(PBS-T) (pH 7.4). After that, sections were blocked with
1.5 % blocking serum solution (from ABC Vectastain Elite
Kit, Vector Laboratories, Burlingame, USA) in PBS-T, for
30 min. Slides were incubated with the primary antibody
overnight at 4 °C. Primary antibodies used included rabbit
polyclonal anti-DDX4 IgG (1:200; Abcam, Cambridge, UK),
and anti-IFITM3 (1:300; Abcam, Cambridge, UK).Secondary antibody used was a goat anti-rabbit IgG (ABC
Vectastain Elite Kit, Vector Laboratories, Burlingame, USA)
for 30 min at room temperature followed by incubation
with avidin-biotinn complex (ABC Vectastain Elite Kit, Vec-
tor Laboratories, Burlingame, USA) for additional 30 min at
room temperature. The reaction was visualized with 3,3'- di-
aminobenzidine chromogen containing nickel salt (DAB
Kit, Vector laboratories, Burlingame, USA). The sections
were dehydrated, and coverslipped. Images were captured
and analyzed using an optic microscope (BX40, Olympus
Optical Corporation, Tokyo, Japan), with a digital camera
(390CU 3.2 Megapixel CCD Camera, Micrometrics, Spain).Immunofluorescence and co-localization
Paraffin sections were dewaxed in xylene and hydrated
through decreasing ethanol. After 10 min in PBS, the heat-
induced epitope retrieval was performed by thermal bath at
96 °C in 10 mM sodium citrate at pH 6 during 20 min.
After that, sections were blocked with blocking serum solu-
tion (Vector Laboratories, Burlingame, USA) diluted in
1.5 % PBS-T for 30 min. Slides were incubated with the pri-
mary antibody overnight at 4 °C. Primary antibodies used
included rabbit polyclonal Ig-G anti DDX4 (1:200; Abcam,
Cambridge, UK), anti IFITM3 (1:300; Abcam, Cambridge,
UK), anti OCT4 (1:300; Abcam, Cambridge, UK), anti
PCNA (1:300; Abcam, Cambridge, UK), anti ESR1 (1:100;
Santa Cruz Biotechnology Inc., Dallas, Texas, USA), and
mouse monoclonal Ig-G anti CD45 (1:100; Dako,
Copenhagen, Denmark). Secondary antibodies used were
goat anti-rabbit FITC (1:500; Chemicon, EMD Millipore
Corporation, Billerica, Massachusetts, USA), donkey
anti-rabbit Alexa 555 (1:600; Invitrogen, Life Technologies
Corporation, Carlsbad, California, USA), and goat
anti-mouse FITC (1:300; Chemicon, EMD Millipore
Corporation, Billerica, Massachusetts, USA) for 60 min at
room temperature. The slides were counterstained with
mounting medium for fluorescence with DAPI (H-1200;
Vector Laboratories, Burlingame, USA). Negative controls
were performed by omitting the primary antibody. Images
were analyzed using an optic microscope (Olympus BX40)
and captured with an attached digital camera (390CU 3.2
Megapixel CCD Camera, Micrometrics, Spain). Colon and
ovary sections were used as positive control for IFITM3
and DDX4 antibodies, respectively.
Co-localization was performed initially in the same
way as immunofluorescence, but after the first second-
ary antibody, the slides were rinsed twice with PBS-T
for 10 min each. Then, the sections were blocked with
blocking serum solution (Vector Laboratories, Burlin-
game, USA) diluted in 1.5 % in PBS-T for 30 min. After
that, the slides were incubated with a second primary
antibody overnight at 4 °C and then washed and incu-
bated with the appropriate secondary antibody for
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terstained as indicated above.RNA extraction and RT-PCR
Total RNA was extracted from paraffin embedded
samples using the RNeasy FFPE kit (Qiagen, Hilden,





C-3'. The RT-PCR was performed using QIAGEN
One-step RT-PCR kit (Qiagen, Hilden, Germany).Fig. 1 General histology and immunohistochemistry for IFITM3 and DDX4
the wall of the endometriotic cyst, b. General view of an endometriotic cys
view of IFITM3 immunodetection with detection of sparse cells with specif
detect dispersed cells showing positive reaction (inset), e. Normal endo
endometrial tissue negative for DDX4 immunohistochemistry. Bar = 50 μmResults
Identification of DDX4 and its association with hormonal,
proliferation and stem cell markers
All samples were first inspected for general histology
by hematoxylin-eosin (HE) staining and subjected to
exploratory immunohistochemistry (IHC) for DDX4
and IFITM3 markers (Fig. 1). Although in some cases
a clean HE was observed (Fig. 1a), most of the sam-
ples showed important amounts of hemorrhagic deb-
ris (Fig. 1b) yielding unspecific precipitates in IHC
(Fig. 1c, d). However, a thorough inspection led to
identify sparse cells displaying suspected specific sig-
nals both for IFITM3 (Fig. 1c) and DDX4 (Fig. 1d)
mostly located near the borders of the endometrioticproteins in endometriotic cysts. a Hematoxylin-eosin general view of
t showing large amounts of haemorrhagic debris (arrows), c. General
ic signals (inset), d. DDX4 immunohistochemistry also enabled to
metrial tissue showing no positive cells for IFITM3, and f. Normal
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tected in control endometrial tissue both for IFITM3 and
DDX4 proteins (Fig. 1e, f).
All samples were then thoroughly analyzed by im-
munofluorescence. In all endometriotic samples, DDX4-
positive cytoplasmic staining in stromal cells, isolated or
in clusters, were undoubtedly detected (Fig. 2a). No
DDX4-positive cells were detected in the 4 normal endo-
metrial tissues inspected. Although not quantified, posi-
tive cells were low in numbers; however, samples fromFig. 2 Immunofluoresecent detection of DDX4 in ovarian endometriosis le
a. Co-expression of DDX4 and ESR1. DDX4 was detected in cytoplasm of is
the nucleus of the cells with positive cytoplasmatic staining for DDX4 (inse
of cells with strong positive nuclear staining for PCNA (inset). c Co-expression
was observed in the cytoplasm (asterisk). The inset shows a detail of n
signal for DDX4 protein. Bar = 50 μmyounger patients seemed to display higher numbers
since positive cells were more easily found. PCR-analysis
confirmed DDX4-mRNA expression in endometriotic
samples (Fig. 3c).
We further studied the relationship between DDX4
and the characteristic hyper-estrogenic hormonal en-
vironment of this disease analyzing the co-expression
of DDX4 and ESR1. In all pathological samples, we
observed ESR1 staining in the nucleus of DDX4-
positive cells (Fig. 2a). Additionally, DDX4-expressingsions and its relation to hormonal, stem cell and proliferation markers.
olated cells and clusters of cells (dashed line). ESR1 was observed in
t). b Co-expression of DDX4 and PCNA. DDX4 was observed in cytoplasm
of DDX4 and OCT4. OCT4 was mainly nuclear (arrows), but it also
uclear staining (dashed line). d CD45-positive cells did not show
Fig. 3 Expression of IFITM3 in ovarian endometriosis lesions and RT-PCR for DDX4 and IFITM3. a IFITM3 was detected in cytoplasm of isolated
cells and in clusters of cells (dashed line). b DDX4 and IFITM3 proteins co-localized in the cytoplasm in the same cells in endometriosis lesions.
c DDX4 and IFITM3 were detected through RT-PCR in ovarian endometriosis. Endometrial tissue was negative. Bar = 50 μm
Fraunhoffer et al. Journal of Ovarian Research  (2015) 8:66 Page 5 of 7cells were positive for the proliferating marker PCNA
(Fig. 2b) and, some of them, also showed a weak
OCT4 cytoplasmic expression (Fig. 2c). On the other
hand, cells expressing CD45 lymphocyte marker did
not show signals for DDX4 (Fig. 2d).
Identification of IFITM3 and its association with DDX4
A homogeneous cytoplasm distribution of IFITM3 immu-
nolabelling was found in isolated cells and clusters of cells
in all endometriosis samples (Fig. 3a). Moreover, IFITM3
co-localized with DDX4 (Fig. 3b). No positive IFITM3 im-
munostaining was detected in normal endometrial tissue.
The expression of IFITM3 in ovarian endometriosis le-
sions was confirmed by RT-PCR (Fig. 3c) and normal
endometrial tissues were negative for IFITM3-mRNA.
Discussion
We identified DDX4 and IFITM3 proteins in isolated
and clusters of cells in ovarian endometriosis lesions.
DDX4 and IFITM3 are essential proteins for homing
and maturation of germ cells [18, 19] that were used for
isolation and purification of female germ line stem cells
[13, 20]. DDX4/IFITM3-positive cells in endometriotic
lesions also expressed, although weakly, OCT4 protein, a
transcriptional factor necessary for maintaining the self-
renewal and pluripotency phenotype of embryonic
stem cells. Moreover, they expressed PCNA indicatingself-renewal capacity and/or the mitotic activity of these
cells. Thus, the finding of cells displaying germ cell-
specific DDX4 and IFITM3 proteins suggests an ovarian
origin, and as far as we could track in the literature this is
the first evidence reported for ovarian-sourced cells in the
endometrioma. In line with this, expression of pluripo-
tency markers such as OCT4 and NANOG and the proto-
ncogene c-KIT in stem-like cells in endometriosis have
been described and related to the development of the dis-
ease and progression towards ovarian cancer [9, 21].
Nevertheless, the presence of ovarian germ line stem cells
as contributors to endometriosis progression remains to
be further studied through functional analysis in isolated
DDX4/IFITM3-positive cells.
Alternatively to the prevailing theory of retrograde
menstruation, it has been suggested that a small popula-
tion of mesenchymal stem cells (eMSC) residing in the
normal endometrial tissue may contribute to endometri-
osis progression [6, 7]. It is not possible to rule out that
DDX4/IFITM3-positive cells are related to eMSC since
weak expression of OCT4 may indicate differentiation
towards stromal cells. However, the absence of DDX4/
IFITM3-positive cells in normal endometrial tissue
advocates in favour of an ovarian origin. Whatever the
case may be, the identification of ovarian germ line and
endometrial mesenchymal stem cells in endometriosis
lesions adds up new ways in the understanding of this
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How stem cells may contribute to disease progression
could be related to the hyperstrogenic environment that
characterizes endometriosis, contributed by both systemic
and locally synthesized estrogens [22]. Estrogen acts as a
proliferation and differentiation agent not only in eutopic
but also in ectopic endometrial cells [23]. In line with this,
DDX4/IFITM3-positive cells were found to express ESR1
and revealed renewal activity by expressing PCNA.
Besides their essential role in germ line commitment,
DDX4 and IFITM3 expression is also associated with
other processes such as cell cycle progression [24, 25]
and antiviral activity [26, 27]. IFITM3 is over expressed
in different types of cancers, such as breast [28, 29], pro-
moting epithelial-mesenchymal transition through the
Wnt/β-catenin signaling. On the other hand, DDX4 re-
duces the expression of 14-3-3σ, which serves as a regu-
lator for G2 checkpoint [25, 30]. Many reports have
demonstrated the loss of expression of 14-3-3σ in hu-
man cancers [31, 32]. Furthermore, the relationship be-
tween endometriosis and cancer progression has been
reported in endometriod epithelial ovarian cancer and
ovarian clear cell carcinoma [33]. In this context, up
regulation of DDX4 and IFITM3 proteins in ovarian-
sourced stem cells, as well as OCT4 in eMSC, could
correlate with the molecular pathway towards the malig-
nant forms of the endometriosis lesion.
In conclusion, the data reported here identified DDX4-
and IFITM3-expressing cells, two germ line-specific
proteins, in ovarian endometriotic lesions, most likely
arising from ovarian-sourced stem cells, suggesting a
possible involvement of ovarian stem cells in the devel-
opment of the endometrioma. This finding opens new
doors towards deepening the understanding of this
pathology and its progression.
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